DASFREE: Treatment-Free Remission (TFR) After Discontinuation of Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR)

Clinical Lymphoma Myeloma and Leukemia(2019)

引用 1|浏览25
暂无评分
关键词
treatment-free remission,dasatinib,imatinib,CML-CP,CML,chronic myelogenous leukemia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要